SPH SINCLAIR PHARMA PLC ORD 1P
| Income Statement |
30-Jun-12 ( £ m ) |
30-Jun-13 ( £ m ) |
30-Jun-14 ( £ m ) |
30-Jun-15 ( £ m ) |
31-Dec-16 ( £ m ) |
|---|---|---|---|---|---|
| Continuing Operations | |||||
| Revenue | 51.42 | 55.38 | 63.56 | 27.84 | 45.49 |
| Operating Profit/(Loss) | -4.95 | -15.33 | -1.79 | -11.73 | -18.24 |
| Net Interest | 1.18 | 0.80 | 2.07 | 5.65 | 2.65 |
| Profit Before Tax | -6.23 | -16.98 | -4.44 | -24.43 | -34.03 |
| Profit After Tax | -5.10 | -15.85 | -4.09 | -23.37 | -33.40 |
| Discontinued Operations | |||||
| Profit After Tax | -3.54 | -1.52 | -1.21 | 16.16 | 4.62 |
| PROFIT FOR THE PERIOD | -8.64 | -17.36 | -5.30 | -7.21 | -28.78 |
| Attributable to: | |||||
| Minority Interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Holders of Parent Company | -8.64 | -17.36 | -5.30 | -7.21 | -28.78 |
| Continuing EPS | |||||
| Earnings per Share - Basic | -1.30p | -3.70p | -0.90p | -4.70p | -6.70p |
| Earnings per Share - Diluted | -1.30p | -3.70p | -0.90p | -4.70p | -6.70p |
| Earnings per Share - Adjusted | -1.30p | 0.70p | 1.30p | -4.70p | -6.70p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share - Basic | -2.20p | -4.10p | -1.20p | -1.50p | -5.90p |
| Earnings per Share - Diluted | -2.20p | -4.10p | -1.20p | -1.50p | -5.90p |
| Earnings per Share - Adjusted | -2.20p | 0.30p | 1.00p | -1.50p | -5.90p |
| Dividend per Share | 0.00p | 0.00p | 0.00p | 0.00p | 0.00p |
| Balance Sheet |
30-Jun-12 ( £ m ) |
30-Jun-13 ( £ m ) |
30-Jun-14 ( £ m ) |
30-Jun-15 ( £ m ) |
31-Dec-16 ( £ m ) |
|---|---|---|---|---|---|
| Assets | |||||
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0.84 | 0.50 | 1.40 | 1.71 | 1.68 |
| Intangible Assets | 129.63 | 121.36 | 241.54 | 232.28 | 148.88 |
| Investment Properties | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.13 | 0.16 | 0.16 | 0.17 | 0.10 |
| Other Financial Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 4.81 | 4.16 | 3.85 | 3.31 | 0.00 |
| 135.40 | 126.17 | 246.95 | 237.47 | 150.66 | |
| Current Assets | |||||
| Inventories | 5.83 | 4.85 | 7.60 | 7.62 | 3.84 |
| Trade & Other Receivables | 16.78 | 19.94 | 29.54 | 27.66 | 13.33 |
| Cash at Bank & in Hand | 4.04 | 5.06 | 17.53 | 12.66 | 16.77 |
| Current Asset Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.43 | 0.00 | 1.10 | 0.00 | 0.00 |
| 27.08 | 29.85 | 55.77 | 47.95 | 33.94 | |
| Total Assets | 162.48 | 156.02 | 302.72 | 285.42 | 184.60 |
| Liabilities | |||||
| Current Liabilities | |||||
| Borrowings | -3.12 | -3.42 | -1.24 | -21.86 | -4.40 |
| Other Current Liabilities | -17.34 | -20.61 | -41.64 | -24.89 | -22.48 |
| -20.46 | -24.03 | -42.88 | -46.75 | -26.88 | |
| Net Current Assets | 6.62 | 5.82 | 12.89 | 1.20 | 7.06 |
| Non-Current Liabilities | |||||
| Borrowings | -9.98 | -8.50 | -53.32 | -95.75 | -31.88 |
| Provisions | -15.34 | -10.93 | -27.04 | -26.70 | -24.07 |
| Other Non-Current Liabilities | -2.41 | -2.02 | -61.57 | -10.64 | -1.45 |
| -27.74 | -21.45 | -141.93 | -133.10 | -57.40 | |
| Other Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Liabilities | -48.20 | -45.48 | -184.80 | -179.85 | -84.28 |
| Net Assets | 114.28 | 110.54 | 117.92 | 105.57 | 100.32 |
| Capital & Reserves | |||||
| Share Capital | 4.03 | 4.35 | 4.97 | 4.97 | 5.02 |
| Share Premium Account | 58.73 | 67.24 | 86.14 | 86.13 | 86.13 |
| Other Reserves | 100.67 | 104.83 | 96.97 | 90.41 | 112.46 |
| Retained Earnings | -49.15 | -65.88 | -70.16 | -75.94 | -103.29 |
| Shareholders Funds | 114.28 | 110.54 | 117.92 | 105.57 | 100.32 |
| Minority Interests/Other Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 114.28 | 110.54 | 117.92 | 105.57 | 100.32 |
| Ratios - based on IFRS | 30-Jun-12 | 30-Jun-13 | 30-Jun-14 | 30-Jun-15 | 31-Dec-16 |
|---|---|---|---|---|---|
| Continuing Operations | |||||
| PE Ratio - Adjusted | -20.58 | 37.86 | 24.62 | -8.51 | -5.04 |
| PEG - Adjusted | n/a | n/a | 0.29 | n/a | n/a |
| Earnings per Share Growth - Adjusted | n/a | n/a | 85.71% | n/a | n/a |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Revenue Per Share | 13.13p | 12.98p | 14.29p | 5.60p | 9.14p |
| Pre-Tax Profit per Share | -1.59p | -3.98p | -1.00p | -4.92p | -6.84p |
| Operating Margin | -9.84% | -29.22% | -3.74% | -67.44% | -68.98% |
| Return on Capital Employed | -38.61 % | -134.55 % | 5.65 % | -106.67 % | -266.15 % |
| Continuing & Discontinued Operations | |||||
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend per Share Growth | n/a | n/a | n/a | n/a | n/a |
| Net Asset Value per Share (exc. Intangibles) | -3.81p | -2.49p | -24.85p | -25.47p | -9.67p |
| Net Gearing | 7.93% | 6.20% | 31.40% | 99.41% | 19.45% |
Data provided by Morningstar
Company Information
| Updated Monthly | |
|---|---|
| Company address | 1st Floor, Whitfield Court, 30-32 Whitfield Street, London, W1T 2RQ, United Kingdom |
| Company website | http://www.sinclairphar... |
| Market cap(in millions)* | £ 134.76 |
| Listing/Admission to trading | 16 Apr 2007 |
| Trading service | SETS |
| Market | AIM |
| Listing category | - |
Trading Information
| 25-Sep-17 | |
|---|---|
| FTSE index | FTSE AIM All-Share,FTSE AIM All-Share - Health Care |
| FTSE sector | Pharmaceuticals & Biotechnology |
| FTSE sub-sector | Pharmaceuticals |
| Country of share register | GB |
| Segment | AMSM |
| MiFID Status | MTF |
| Exchange market size | 10,000 |
| SEDOL | 3385674 |
| ISIN number | GB0033856740 |